Initial studies indicate that Retatrutide – a dual agonist of GLP-1 and glucose-dependent insulinotropic polypeptide receptors – presents a significant improvement in weight reduction programs . Unlike existing treatments , Retatrutide shows to modify hunger and energy burn by means of distinct pathways . Although additional analysis is requir